Boxed Warning for Allergy Drug

The FDA is requiring that the allergy and asthma medication montelukast carry a boxed warning —its most prominent type of alert—to caution consumers and clinicians about the risk of neuropsychiatric events associated with the drug. Montelukast is marketed as Singulair and in generic form.
Source: JAMA - Category: General Medicine Source Type: research